nhs scotland

Showing 10 posts of 10 posts found.


Forxiga accepted for use within NHS Scotland for chronic heart failure

April 14, 2021
Research and Development AstraZeneca, nhs scotland

AstraZeneca have announced that Forxiga (dapagliflozin) has been accepted for use within NHS Scotland by the Scottish Medicines Consortium (SMC) …


Alexion’s Ondexxya approved for NHS Scotland to treat uncontrolled and life-threatening bleeds

September 9, 2020
Research and Development, Sales and Marketing Alexion, NHS, Ondexxya, Scotland, nhs scotland

The Scottish Medicines Consortium (SMC) has given its recommendation to Alexion’s Ondexxya (andexanet alfa) to routine use on NHS Scotland …


Scottish Medicines Consortium enables access to treatment for rare inherited bone disorder in children

February 18, 2020
Manufacturing and Production Crysvita, Kyowa Kirin, SMC, Scottish Medicine Consortium, nhs scotland

The Scottish Medicines Consortium (SMC) has enabled access to Kyowa Kirin’s Crysvita (burosumab) for the NHS in Scotland to treat …


Sanofi and Regeneron’s Libtayo approved on NHS Scotland for cutaneous squamous cell carcinoma

February 11, 2020
Manufacturing and Production, Sales and Marketing Libtayo, NHS, Regeneron, Sanofi, Scotland, nhs scotland, pharma

Scottish patients will now be able to access Sanofi and Regeneron’s Libtayo (cemiplimab) via the NHS after it became known …

HIV infections fall by 73% in bi and gay British men

January 16, 2020
Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland

Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …


NHS Scotland recommends Janssen’s Zytiga combo for newly diagnosed prostate cancer

January 13, 2020
Sales and Marketing Cancer, NHS, Scotland, nhs scotland, prostate cancer

Janssen’s Zytiga (abiraterone acetate) has just been approved by the Scottish Medicines Consortium (SMC), meaning that male patients on the …


NHS Scotland gives green light to funding haemophilia A drug Hemlibra

December 18, 2019
Research and Development NHS, haemophilia, haemophilia B, haemophilia a, nhs scotland

NHS Scotland has commissioned Hemlibra (emicizumab), by Chungai Pharma UK Ltd and Roche Products Ltd, to treat people with congenital …


Camurus’ weekly/monthly opioid dependence injection accepted in Scotland for NHS use

August 13, 2019
Manufacturing and Production, Sales and Marketing Camurus, NHS, Scotland, nhs scotland, opioid dependence, opioids, pharma

The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous injection) from Swedish pharma …

Safe Patient Systems platform image

NHS in Scotland deploys mobile healthcare

August 13, 2014
Medical Communications, Sales and Marketing NHS, Safe Patient Systems, Scotland, digital, nhs scotland, tablets

Mobile healthcare firm Safe Patient Systems is partnering with NHS Greater Glasgow and Clyde (NHSGGC) to provide mobile healthcare services …

Rise in diabetes ‘alarming’

July 7, 2014
Sales and Marketing NHS, diabetes, nhs scotland, type 2

NHS Scotland has spent around £230 million on diabetes and obesity drugs in the past three years, according to data …

Latest content